StonvexLoading…
StonvexStonvexStonvexCore line items from AXR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $49.69M | $51.37M | $48.68M | $58.93M |
Operating Income | $12.11M | $7.60M | $5.83M | $21.30M |
Net Income | $12.72M | $6.69M | $21.79M | $15.86M |
EPS (Diluted) | $2.37 | $1.25 | $4.11 | $2.21 |
Total Assets | $133.78M | $122.83M | $115.89M | $94.92M |
Total Liabilities | $3.81M | $4.78M | $4.89M | $11.76M |
Cash & Equivalents | $39.47M | $29.69M | $19.99M | $15.72M |
Free Cash Flow OCF − CapEx | $9.66M | $10.26M | $6.26M | $14.19M |
Shares Outstanding | 5.37M | 5.35M | 5.31K | 7.19K |